Literature DB >> 24592042

A new way of setting rFSH deposit: a case of severe injection error in IVF/ICSI cycle ending with live birth.

Richard Bernhard Mayer1, Thomas Ebner1, Omar Shebl1, Gernot Tews1.   

Abstract

WE PRESENT A CASE WITH A SEVERE INJECTION ERROR: a 25- year old woman with secondary infertility caused by a male factor was enrolled in our IVF/ICSI-ET program. Stimulation was performed in a long- protocol and ovarian stimulation, using rFSH follitropin beta, starting on the third day of the menstrual cycle. The rFSH dose per day was 900 IU-0 IU-0 IU-0 IU. Due to normal ovarian response and follicle growth, stimulation was continued and there was no detriment in oocyte quality and no symptoms of OHSS. Following blastocyte transfer cesarean section was unpreventable at 37+5 weeks of gestation due to an impacted transverse lie. Different stimulation protocols are needed for appropriate treatment of various patients provided that the administration of treatment was done correctly. In the case of injection errors, continuing stimulation protocol seems to be achievable in certain cases considering hormone levels and the process of follicle growth.

Entities:  

Keywords:  Assisted reproductive technique; live birth; long protocol; rFSH; severe injection error

Year:  2012        PMID: 24592042      PMCID: PMC3939245          DOI: 10.5152/jtgga.2012.32

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  13 in total

Review 1.  Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS.

Authors:  Mohamed Aboulghar
Journal:  Hum Reprod       Date:  2003-06       Impact factor: 6.918

Review 2.  Outlook: who needs LH in ovarian stimulation?

Authors:  C Alviggi; R Clarizia; A Mollo; A Ranieri; G De Placido
Journal:  Reprod Biomed Online       Date:  2006-05       Impact factor: 3.828

3.  Age-related distribution of basal serum AMH level in women of reproductive age and a presumably healthy cohort.

Authors:  Omar Shebl; Thomas Ebner; Andreas Sir; Elisabeth Schreier-Lechner; Richard B Mayer; Gernot Tews; Michael Sommergruber
Journal:  Fertil Steril       Date:  2011-02       Impact factor: 7.329

Review 4.  Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment.

Authors:  D Navot; P A Bergh; N Laufer
Journal:  Fertil Steril       Date:  1992-08       Impact factor: 7.329

5.  Psychosocial experiences in women facing fertility problems--a comparative survey.

Authors:  B J Oddens; I den Tonkelaar; H Nieuwenhuyse
Journal:  Hum Reprod       Date:  1999-01       Impact factor: 6.918

Review 6.  Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy.

Authors:  B M Mannaerts; F Rombout; H J Out; H Coelingh Bennink
Journal:  Hum Reprod Update       Date:  1996 Mar-Apr       Impact factor: 15.610

7.  Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.

Authors:  A La Marca; S Giulini; A Tirelli; E Bertucci; T Marsella; S Xella; A Volpe
Journal:  Hum Reprod       Date:  2006-10-27       Impact factor: 6.918

8.  A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.

Authors:  Kannamannadiar Jayaprakasan; Bruce Campbell; James Hopkisson; Ian Johnson; Nick Raine-Fenning
Journal:  Fertil Steril       Date:  2008-11-30       Impact factor: 7.329

9.  Understanding the burden of ovarian stimulation: fertility expert and patient perceptions.

Authors:  D Huisman; X Raymakers; E Hm Hoomans
Journal:  Reprod Biomed Online       Date:  2009       Impact factor: 3.828

10.  Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteers.

Authors:  B Mannaerts; Z Shoham; D Schoot; P Bouchard; J Harlin; B Fauser; H Jacobs; F Rombout; H Coelingh Bennink
Journal:  Fertil Steril       Date:  1993-01       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.